Tarsus Pharmaceuticals Inc
NASDAQ:TARS

Watchlist Manager
Tarsus Pharmaceuticals Inc Logo
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Watchlist
Price: 51.74 USD 2.15% Market Closed
Market Cap: 2B USD

Intrinsic Value

The intrinsic value of one TARS stock under the Base Case scenario is 60.64 USD. Compared to the current market price of 51.74 USD, Tarsus Pharmaceuticals Inc is Undervalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TARS Intrinsic Value
60.64 USD
Undervaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Tarsus Pharmaceuticals Inc

TARS
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for TARS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Tarsus Pharmaceuticals Inc
NASDAQ:TARS
US
Pharmaceuticals
Market Cap
2B USD
IPO
Oct 16, 2020
US
Pharmaceuticals
Market Cap
2B USD
IPO
Oct 16, 2020
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TARS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Tarsus Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tarsus Pharmaceuticals Inc

Current Assets 356.7m
Cash & Short-Term Investments 291.4m
Receivables 48.1m
Other Current Assets 17.3m
Non-Current Assets 20.3m
Long-Term Investments 3m
PP&E 2.9m
Intangibles 8.3m
Other Non-Current Assets 6.1m
Efficiency

Free Cash Flow Analysis
Tarsus Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Tarsus Pharmaceuticals Inc

Revenue
183m USD
Cost of Revenue
-12.8m USD
Gross Profit
170.1m USD
Operating Expenses
-290.7m USD
Operating Income
-120.6m USD
Other Expenses
5m USD
Net Income
-115.6m USD
Fundamental Scores

TARS Profitability Score
Profitability Due Diligence

Tarsus Pharmaceuticals Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
33/100
Profitability
Score

Tarsus Pharmaceuticals Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

TARS Solvency Score
Solvency Due Diligence

Tarsus Pharmaceuticals Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Low D/E
70/100
Solvency
Score

Tarsus Pharmaceuticals Inc's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TARS Price Targets Summary
Tarsus Pharmaceuticals Inc

Wall Street analysts forecast TARS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TARS is 68.98 USD with a low forecast of 45.45 USD and a high forecast of 89.25 USD.

Lowest
Price Target
45.45 USD
12% Downside
Average
Price Target
68.98 USD
33% Upside
Highest
Price Target
89.25 USD
72% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Tarsus Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TARS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

TARS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TARS stock?

The intrinsic value of one TARS stock under the Base Case scenario is 60.64 USD.

Is TARS stock undervalued or overvalued?

Compared to the current market price of 51.74 USD, Tarsus Pharmaceuticals Inc is Undervalued by 15%.

Back to Top